Table 1 : Serum Annexin A2 (ANXA2) and Alpha fetoprotein (AFA)
in different studied groups compared to the healthy control group.
ANXA2 | |||
Group | n | ng/ml | P-value |
Control Chronic hepatitis Fibrosis Cirrhosis Early HCC Late HCC |
40 6 8 6 8 12 |
10.67±2.89 11.78±1.40 16.34±3.96 18.45±3.27 33.85±3.59 36.89±5.22 |
-- P=0.583 P<0.03* P<0.04* P<0.000*** P<0.000*** |
AFP | |||
Group | n | IU/ml | P-value |
Control Chronichepatitis Fibrosis Cirrhosis Early HCC Late HCC |
40 6 8 6 8 12 |
4.02 ±0.97 17.45±2.33 21.65±4.65 37.45±2.92 39.34±4.57 320.23±13.68 |
-- P<0.02* P<0.001** P<0.001** P<0.001** P<0.000*** |